Cadrenal Therapeutics News and Activities

View the org chart displaying its 8 main executives

Most searched biographies at Cadrenal Therapeutics

• Quang Pham, Chief Executive Officer, Chairman of the Board interim...
• Steven Zelenkofske, Director
• Lee Scott Golden, Director

Popular executive movements at Cadrenal Therapeutics

• Matthew Szot, Chief Financial Officer, has left the company  (posted on June 4 2026).
• Quang Pham who was Chief Executive Officer and Chairman of the Board, becomes Chief Executive Officer, Chairman of the Board interim Chief Financial Officer and interim Principal Accounting Officer  (posted on June 4 2026).
• Lee Scott Golden has joined the company as Director  (posted on December 2 2025).

Create your alert
to follow the executive moves at Cadrenal Therapeutics.

Cadrenal Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Cadrenal Therapeutics

• Press Releases - Cadrenal Therapeutics, Inc.

Social media about Cadrenal Therapeutics

• Cadrenal Therapeutics on Wikipedia, Google News & Yahoo Finance
• Cadrenal Therapeutics on LinkedIn, X (Twitter) & YouTube